The Principal Investigator's long-term goal is to direct a basic science research program exploring the pathogenesis of kidney fibrosis. To achieve this goal he has entered a post-doctoral fellowship program, which is centered around extracellular matrix biology following his research training in renal fibroblast and tubular epithelial cell biology coupled with a clinical Nephrology clerkship at the University of Goettingen in Germany. The current postdoctoral fellowship research is conducted under supervision of Dr. Raghu Kalluri. His laboratory is well suited to provide guidance in established and new molecular techniques and transgenic animal studies to foster the start of an independent career. The research project proposed here centers on exploring endogenus regenerative mechanisms, which facilitate protection from kidney injury and its use in designing therapies to protect the kidney from chronic progressive kidney disease. The central hypothesis of this proposal is that the recovery from renal injury follows pathways, which are similar to those, which mediate kidney development. Such thinking is based on previous studies, which demonstrate that administration of bone morphogenic protein-7 (BMP-7), a growth factor involved in tubulogenesis during kidney development, facilitates regression of chronic kidney disease. These previous studies suggest that BMP-7 may reverse epithelial to mesenchymal transition (EMT) involving injured tubular epithelial cells, leading to accumulation of fibroblasts. Additionally, BMP-7 also induces phenotypic changes in medullary renal fibroblasts resembling mesenchymal to epithelial transition, regenrating epithelial cells. The study aims proposed in this application are centered around testing the potential role of fibroblasts in the repair of renal injury and they attempt to further analyze the preliminary phenotypic observation at a molecular level.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Clinical Investigator Award (CIA) (K08)
Project #
Application #
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Rankin, Tracy L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Beth Israel Deaconess Medical Center
United States
Zip Code
Sugimoto, Hikaru; LeBleu, Valerie S; Bosukonda, Dattatreyamurty et al. (2012) Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med 18:396-404
O'Connell, Joyce T; Sugimoto, Hikaru; Cooke, Vesselina G et al. (2011) VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci U S A 108:16002-7
Zeisberg, Michael; Neilson, Eric G (2010) Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21:1819-34
Bechtel, Wibke; McGoohan, Scott; Zeisberg, Elisabeth M et al. (2010) Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 16:544-50
Flier, Sarah N; Tanjore, Harikrishna; Kokkotou, Efi G et al. (2010) Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem 285:20202-12
Zeisberg, Michael; Duffield, Jeremy S (2010) Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21:1247-53
Zeisberg, Michael; Neilson, Eric G (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119:1429-37
Zeisberg, Elisabeth M; Potenta, Scott E; Sugimoto, Hikaru et al. (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19:2282-7
Zeisberg, Michael; Kalluri, Raghu (2008) Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis. Front Biosci 13:6991-8
Zeisberg, Michael; Kalluri, Raghu (2008) Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease. Pediatr Nephrol 23:1395-8

Showing the most recent 10 out of 15 publications